Clinical Trial Update: Depression Treatment and Risk for Cardiovascular Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating a depression treatment and its impact on cardiovascular risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: East Carolina University | Conditions: Depression | Phase 1, Phase 2 | Status: COMPLETED